Covestro Q2 Sales Down 8.4 Percent EBITDA Drops to €270 Million Outlook Cut Amid Tariff Shock and Price Squeeze
Covestro’s Q2 2025 results reveal a sharp setback as global headwinds—including sudden US tariff hikes and persistent oversupply—dragged group sales down 8.4% to €3.4 billion and EBITDA down 15.6% to €270 million. Net loss narrowed year-on-year to -€59 million, but free operating cash flow worsened to -€228 million. While volumes held steady, lower average selling prices and currency swings weighed heavily on performance.
CEO Dr. Markus Steilemann flagged the unexpected impact of escalating tariffs, which hammered US-bound exports and triggered a global supply glut, slashing prices across key markets. Although Covestro hit the upper end of its guidance thanks to a €44 million bonus provision reversal, the company now expects full-year EBITDA of €700–1,100 million, down from a previous €1–1.4 billion range, and has revised its free cash flow outlook to -€400 to €100 million.
The Functional Materials division took the brunt, with Q2 sales sliding 11.8% to €1.6 billion and EBITDA down to €149 million, hurt by margin erosion and transformation costs. In contrast, Solutions & Specialties saw sales dip only 5.4% to €1.7 billion, with EBITDA inching up to €175 million, buoyed by solid volumes and lower transformation expenses.
Covestro is pushing ahead with its “STRONG” transformation program and has moved to acquire Swiss film maker Pontacol, eyeing synergy in specialty films. Meanwhile, Monique Buch will take over as Chief Commercial Officer for Solutions & Specialties from August, strengthening the group’s commercial leadership.
For H1 2025, group sales slid 4.8% to €6.9 billion, EBITDA fell to €407 million, and free cash flow worsened to -€481 million—underscoring relentless price and margin pressure. Despite market turbulence, Covestro’s focus on strategic transformation and disciplined execution may prove decisive for navigating a challenging global landscape.
2026-07-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Lilly’s Mounjaro Enters China’s State Insurance System
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
DKSH to Distribute Exsymol's Silanols, Peptides, and Natural Active Ingredients in South Korea
-
Venator Launches TMP- and TME-Free Titanium Dioxide
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Hengli Sanctions Spill Over: One Barrel of Iranian Crude Pulls an Aromatics Chain Into Risk
-
Chemicals Are Going Wild: Sulfur Surges 512%, Titanium Dioxide, Polyols and Sulfuric Acid Lose Control
-
Global Chemical Inventories Hit Critical Lows as Over 200 Chinese Companies Suspend Quotations
Recommend Reading
-
Egypt’s Chemical Surge: $9.4 Billion Export Boom Signals Industrial Powerhouse Rise
-
India’s API Trade Balance Turns Positive
-
Russia’s Farm Trade Model Shows Strain
-
India Issues Final Anti-Dumping Ruling on Chinese TDQ, with Duties Up to US$549 per Ton
-
New Titanium Dioxide Alternative Moves Closer to Market
-
Weak Demand: Melamine Market Pressured Amid Challenges
-
Supply Eases, Butanol Prices Continue to Decline This Week
-
Epoxy Chloropropane Market Remains Stable This Week (10.13-10.15)
-
ADAMA Targets Sucking Pests with Ateka
-
EFSA Reviews Clodinafop Risk